Age-related changes of cyclic AMP phosphodiesterase activity in rat brain regions and a new phosphodiesterase inhibitor—Nootropic agent adafenoxate
Authors:
- 1 January 1991
- journal article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 22 (5) , 955-958
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Age-related changes in rat brain muscarinic receptors and β-adrenoreceptorsGeneral Pharmacology: The Vascular System, 1989
- Age related decline in aluminum-activated human platelet adenylate cyclase: Post-receptor changes in cyclic AMP second messenger signal amplification in normal aging and dementia of the Alzheimer typeLife Sciences, 1986
- Experimental Studies of Ageing: Behavioural and Physiological CorrelatesGerontology, 1986
- A New Generation of Phosphodiesterase Inhibitors: Multiple Molecular Forms of Phosphodiesterase and the Potential for Drug SelectivityJournal of Medicinal Chemistry, 1985
- Significance of phosphodiesterase in the brainLife Sciences, 1981
- Phosphodiesterase inhibitors facilitate memory for passive avoidance conditioningBehavioral and Neural Biology, 1981
- Central neurotransmitters and agingLife Sciences, 1980
- Effect of aging on neurotransmitter receptor binding in rat and human brainLife Sciences, 1979
- [3H]Haloperidol and [3H]spiroperidol binding in rat striatum during ageingJournal of Pharmacy and Pharmacology, 1978
- Effect of aging on cyclic AMP levels and adenylate cyclase and phosphodiesterase activities in the rat corpus striatumMechanisms of Ageing and Development, 1977